CDK1 in Breast Cancer: Implications for Theranostic PotentialSepideh Izadi, Farhad Jadidi‐Niaragh, Mehdi Yousefi et al.|Anti-Cancer Agents in Medicinal Chemistry|2020Cited by 169
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancerVahid Karpisheh, Farhad Jadidi‐Niaragh, Mohammad Hojjat‐Farsangi et al.|Prostaglandins & Other Lipid Mediators|2019Cited by 126
Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccineHadi Hassannia, Farhad Jadidi‐Niaragh, Ali Masjedi et al.|Immunology|2019Cited by 102
Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccineMaryam Esmaily, Farhad Jadidi‐Niaragh, Ali Masjedi et al.|Journal of Controlled Release|2020Cited by 94
Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathwayAli Masjedi, Farhad Jadidi‐Niaragh, Hadi Hassannia et al.|International Journal of Biological Macromolecules|2019Cited by 81